Core Laboratories (CLB) Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" CLB shares.
View CLB analyst ratings or view top-rated stocks.

3 equities research analysts have issued 1-year price targets for Core Laboratories' shares. Their CLB share price forecasts range from $19.00 to $26.00. On average, they expect the company's stock price to reach $22.30 in the next year. This suggests that the stock has a possible downside of 13.9%.
View analysts price targets for CLB or view top-rated stocks among Wall Street analysts.

Core Laboratories' stock was trading at $20.27 at the beginning of 2023. Since then, CLB stock has increased by 27.8% and is now trading at $25.91.
View the best growth stocks for 2023 here.

Core Laboratories saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 3,860,000 shares, a decrease of 26.1% from the April 30th total of 5,220,000 shares. Based on an average daily volume of 399,100 shares, the days-to-cover ratio is currently 9.7 days. Approximately 8.4% of the shares of the company are sold short.
View Core Laboratories' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 26th 2023.
View our CLB earnings forecast.

Core Laboratories Inc. (NYSE:CLB) posted its quarterly earnings results on Thursday, February, 2nd. The oil and gas company reported $0.20 EPS for the quarter, topping the consensus estimate of $0.19 by $0.01. The oil and gas company earned $127.57 million during the quarter, compared to the consensus estimate of $130.12 million. Core Laboratories had a trailing twelve-month return on equity of 15.23% and a net margin of 4.72%. Core Laboratories's revenue for the quarter was up 1.9% on a year-over-year basis. During the same period last year, the business posted $0.20 earnings per share.

Core Laboratories announced a quarterly dividend on Wednesday, April 26th. Stockholders of record on Monday, May 8th will be paid a dividend of $0.01 per share on Tuesday, May 30th. This represents a $0.04 annualized dividend and a yield of 0.15%. The ex-dividend date of this dividend is Friday, May 5th.
Read our dividend analysis for CLB.

ETFs with the largest weight of Core Laboratories (NYSE:CLB) stock in their portfolio include Cultivar ETF (CVAR), Invesco Dynamic Oil & Gas Services ETF (PXJ), Invesco S&P SmallCap Energy ETF (PSCE), SPDR S&P Oil & Gas Equipment & Services ETF (XES), iShares U.S. Oil Equipment & Services ETF (IEZ), VanEck Oil Services ETF (OIH), Direxion Daily Oil Services Bull 2X Shares (ONG) and Vanguard Energy ETF (VDE).

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.17%. The dividend payout ratio is 8.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

Core Laboratories updated its second quarter 2023 earnings guidance on Thursday, April, 27th. The company provided earnings per share (EPS) guidance of $0.20-$0.24 for the period, compared to the consensus EPS estimate of $0.21. The company issued revenue guidance of $130.00 million-$135.00 million, compared to the consensus revenue estimate of $132.83 million.

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.33%), Boston Trust Walden Corp (4.49%), State Street Corp (2.74%), Ameriprise Financial Inc. (1.93%), Van ECK Associates Corp (1.83%) and Dimensional Fund Advisors LP (1.70%).
View institutional ownership trends.

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $25.91.

Core Laboratories (NYSE:CLB) has a market capitalization of $1.21 billion and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.50 on an earnings per share basis.

The company employs 3,600 workers across the globe.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (713) 328-2673 or via email at investor.relations@corelab.com.